This research was undertaken with the aim of developing a novel fabrication process to enable integration of a two-electrode system to a hypodermic needle and therefore fabrication of a smart needle. The concept was conceived with the intention of addressing a currently unmet clinical need for a regional anesthetic procedure, ultrasound guided peripheral nerve block (USgPNB). The technique USgPNB refers to a set of medical procedures which block nerve impulse conduction, provide anesthesia and pain relief to facilitate surgical operations or are performed to treat acute or chronic pain. The location of the needle tip relative to the target nerve is crucial to the safe and effective practice of USgPNB. By developing a smart needle, a hypodermic needle integrated with an impedance sensor, bioimpedance can be measured at the needle tip.
Bioimpedance has been used to differentiate between tissue types and therefore has the potential to identify the tissue type located at the needle tip, identifying the needle location within the body. Accurate identification of tissue at the needle tip could provide valuable objective information and inform high stakes procedural decisions prior to injection of local anesthetic in close proximity to neural structures. The inability to objectively identify the exact needle position in relation to nerve structures during USgPNB has been identified as a limitation of the technique [1,2]. Ultrasound guidance has brought significant advancement in the performance of PNB which began by estimating nerve location using anatomical landmarks and knowledge and progressed in later years by the introduction of the nerve stimulation technique.
Now ultrasound guidance enables direct visualisation of target nerves, the needle and spread of anesthetic once the drug has been injected. Despite the fantastic advances ultrasound imaging has provided to the PNB procedure, the subjectivity of interpreting ultrasound images and the inability to objectively identify needle to nerve contact or intra-neural needle positioning has led to the investigation of ways to enhance the technique further by providing information on the identity of tissue type at the needle tip. “Regional anaesthesia always works—provided you put the right dose of the right drug in the right place” [12].
Perioperative nerve injury may occur following anaesthesia and surgery [2,14]. The true incidence of nerve injury following all forms of anaesthesia is unknown. Most data are derived from analyses of closed claims databases in the USA, whereby there is a surprising association between nerve injury and general anaesthesia. The best contemporaneous estimates of nerve injury frequency following peripheral nerve block suggest that injury occurs in 4-6 per 10,000 nerve blocks performed [7,13]. Although rare, iatrogenic nerve injury can have severe implications for the person affected. It may result in permanent loss of sensation and power affecting the area supplied by the injured nerve. Chronic neuropathic pain may accompany the condition. The resultant loss of limb function and chronic pain can have catastrophic physical, psychological, social and economic consequences for the injured party [15].
USgPNB is one example of a procedure that could benefit from a smart needle, a hypodermic needle integrated with an impedance sensor, to determine needle tip location within the body. Limitations remain with the inability to objectively identify the relationship of the needle tip to the nerve prior to injection during USgPNB as mentioned previously. To address this limitation, a hypodermic needle integrated with an impedance sensor was developed that could potentially identify tissue at the needle tip thereby providing objective information indicative of needle tip location. Electrical impedance was identified as a feasible parameter, as impedance has previously been used successfully to detect tissue types in diverse clinical scenarios. The possibility of distinguishing intra-neural from extra-neural tissue based on bioimpedance has already been demonstrated and Kalvøy’s group have made novel investigations regarding needle guidance using bioimpedance [3]. However, additional data is needed to confirm the sensitivity and reproducibility of the technology.
The ratio of neural tissue to non-neural tissue between the different nerves and between different needle positions in the same nerve could be a substantial source of variation in bioimpedance trends for
This means more stroma and connective tissue is present within the epineurium of the brachial plexus the further away the nerve travels from the spinal cord. As the vagus nerve was used to obtain bioimpedance data from in this animal study, the proximal ratio of neural to non-neural tissue is more relevant for this data set as the vagus nerve lies proximal to the brachial plexus.
The sciatic nerve is similar to other peripheral nerves with outer epineural tissue surrounding fat and connective tissue and internal nerve fascicles surrounded by perineurium. The sciatic nerve is divided into tibial and common peroneal compartments in humans. Each compartment is composed of fascicles enveloped by their own epineural tissue. The two compartments, within the sciatic nerve, are separated by a connective tissue-adipose septum, known as the Compton Cruveilhier septum, which runs internally, along the length of the sciatic nerve [4]. The sciatic nerve is flat and large in shape proximally (closer to the spinal cord) and becomes more oval and smaller distally (as it moves further away from the spinal cord). This is related to the size and architecture of the brachial plexus, which changes from an oligofascicular (few fascicles) to a multifascicular pattern as it travels distally [4]. The sciatic nerve is multifascicular throughout and has a different microanatomy. The absolute amount of neural tissue decreased from proximal to distal whereas the non-neural tissue remained about the same. This decrease is attributed to branching off nerve tissue to the upper leg muscles. Consequently, neural to non-neural tissue ratio changed, from proximal to distal, from 2:1 to 1:1 [7, 2].
The first indication of nerve bioimpedance was obtained during the pig carcass study performed at a local abattoir. Nerve bioimpedance could not be obtained during
Prior to device validation in an anesthetised animal model,
The vagus nerve (a nerve lying closer to the spinal cord than the brachial plexus) at the side of the neck was easier to access than the brachial plexus. For this reason, the side of the neck was open dissected to the vagus nerve instead of exposing the brachial plexus. Therefore, bioimpedance data was obtained from the different tissues around the vagus nerve on day 4 – 7 of the animal study.
Femoral, sciatic, brachial and vagus nerves were excised from the nerve locations where the bioimpedance measurements were analysed to validate the nerve type. These slides were prepared in histopathology at Cork University Hospital (CUH) with Haemogylin Van Goss Stain on cross section and longtidutional peripheral nerves. These stained peripheral nerve slides were observed under an electron microscope in life sciences laboratory at Tyndall National Institute (TNI). ImageJ software was used, and clear images of peripheral nerves were exported and analysed. Sketching around the parameters of connective and neural tissue separately the ratios of connective to neural tissue in each peripheral nerve could be calculated.
The research related to animal’s use has been complied to, with all the relevant national regulations and institutional policies for the care and use of animals.
Bioimpedance results from the ultrasound guided tissue identification procedure in the pig carcass did not match previous
This was the first opportunity for the expert in human anatomy to ultrasound image porcine anatomy and attempt to locate and identify different tissue structures. The bioimpedance results on open dissection of the tissues fig. 4 were much closer to what was expected from previous
This was the first and only attempt to date at obtaining bioimpedance of porcine tissues in a freshly slaughtered animal. During bioimpedance measurement of nerve tissue it was noted how fragile and friable the nerve structure was. The nerve was already beginning to disintegrate within the surrounding tissues as measurement was performed thus the bioimpedance results obtained should only represent a rough estimate of the bioimpedance of nerve in live tissue. This pilot study however was not only allowed an indication of bioimpedance of near to live porcine tissues but also allowed testing of a study protocol before use on a live anaesthetized pig. Insights gained from this pilot study enabled refinement of the protocol for bioimpedance measurement of
On observation of the tissue bioimpedance data from live tissues in the first two animals evaluated, it was found to be necessary to assess the repeatability and reproducibility of data provided by the smart needle in live tissues.
Results from these studies, along with pre- and post-testing impedance measurement of NaCl solutions, demonstrated that the data obtained using the smart needle was repeatable and had good reproducibility for most tissues. However, some variation between puncture sites was observed during reproducibility testing [11]. This was expected due to the heterogeneity of biological tissues and was accounted for by taking three bioimpedance measurements at three different puncture sites within proximity to each other, from each tissue at each test site [2].
With respect to this research and the intended application of the technology described, the bioimpedance profiles of the
The histological samples taken at test sites were used to confirm tissue type present at that site and further studied with the ImageJ software and ratios of connective and neural tissue calculated. This study showed a lower impedance observed in the sciatic
These characteristics would influence the bioimpedance of tissues at separate locations and, therefore must be considered when interpreting data and planning any future validation experiments. The results presented within this document, along with evidence of different microanatomies within different peripheral nerves, indicate that the EI properties at each major peripheral nerve site need to be characterised individually. The true location of the sensor on the smart needle once the needle was inserted into the nerve was unknown. Variability of results may also have been influenced by the section of nerve exposed and the location of measurement Figure 2. Clinically, even if a needle enters a peripheral nerve, it might still be inside the connective tissue, not necessarily within the neural fascicle. This also explains the longer block onset times for peripheral nerve blocks as opposed to proximal plexus blocks. Again a few scenarios that could have been possible include the sensor being in contact with (A) neural tissue, (B) non- neural tissue i.e., stroma and connective tissue or (C) may have passed through to the other side of the nerve structure to the outer layer of nerve tissue at the opposite side of the nerve. Again, any or all these scenarios could have affected the data recorded in any of the tests.
It is not possible to determine with accuracy if the needle tip is placed
Further data collection on the real-time bioimpedance measurement of peripheral nerves with a commercially produced Smart Needle and the development of an in-clinical trial would support the animal study. Bioimpedance study of specific needle tip insertion into connective and neural tissue separately, with observation of ratios obtained through histological analysis is required to validate the above hypothesis.
Going forward a data bank of impedance readings needs to be compiled of